Vimarsana
Biggest News Aggregation in the World

Page 17 - Billy Dunn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Billy Dunn Today - Breaking & Trending Today

Baxter restructuring • Oak Street Health names provider wellness chief - Vimarsana News

Baxter restructuring • Oak Street Health names provider wellness chief

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

Eisai's Alzheimer's drug receives FDA approval - Vimarsana News

Eisai's Alzheimer's drug receives FDA approval

The FDA approved lecanemab, an Alzheimer’s drug developed by Eisai Co. Ltd. and Biogen Inc., under its Accelerated Approval pathway.

Source: njbiz.com
Alzheimer's drug lecanemab receives accelerated approval amid safety concerns - Vimarsana News

Alzheimer's drug lecanemab receives accelerated approval amid safety concerns

The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer's disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of

Source: waaytv.com
FDA Approves Alzheimer's Drug That Slowed Cognitive Decline in Clinical Trial - Vimarsana News

FDA Approves Alzheimer's Drug That Slowed Cognitive Decline in Clinical Trial

The FDA’s decision comes after clinical trial results indicated that lecanemab slows cognitive decline somewhat in people with mild impairment from...

BREAKING: FDA approves new experimental drug to treat early Alzheimer's - Vimarsana News

BREAKING: FDA approves new experimental drug to treat early Alzheimer's

The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.